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ABSTRACT
In three patients with catheter-associated candid-
aemia, use of 18F-ﬂuorodeoxyglucose positron
emission tomography (FDG-PET) led to the diag-
nosis of Candida lung abscesses, which was
conﬁrmed by computed tomography and a
favourable response to antifungal therapy. It
was concluded that FDG-PET is a promising
new imaging technique that enables early identi-
ﬁcation of sites of disseminated candidiasis, and
that this technique can be used in the evaluation
of therapy.
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Candida spp. are an important cause of nosocomial
bloodstream infection, and are associated with a
mortality of 30–40% [1]. Patients at high risk for
candidiasis are those receiving total parenteral
nutrition (TPN) and those that are critically ill
[2–4]. Catheter-associated candidaemia may lead
to seeding of Candida spp. to multiple organs.
Timely identiﬁcation and localisation of the infec-
tious lesions are critical, but this is often difﬁcult,
especially in patients without signs indicating a
speciﬁc localisation. The present study reports the
use of 18F-ﬂuorodeoxyglucose positron emission
tomography (FDG-PET) to diagnose three cases of
Candida lung abscess associated with central
venous catheter (CVC)-related candidaemia.
Patient A, a female aged 45 years, had received
TPN since September 2003 because of short bowel
syndrome resulting from acute bowel ischaemia.
In January 2004, she was admitted with fever.
Repeated blood cultures grew Candida albicans,
which was also cultured from the catheter tip
after removal, with a ﬂuconazole MIC of
0.125 mg ⁄L. Ophthalmological examination reve-
aled lesions compatible with Candida chorioreti-
nitis. The patient was treated with intravenous
ﬂuconazole 400 mg daily, but the fever persisted.
Blood cultures remained positive for C. albicans
for 7 days after the start of ﬂuconazole therapy,
and the dose was increased to 800 mg daily. Chest
X-ray and abdominal ultrasound were both nor-
mal. Nine days after admission, FDG-PET was
performed, which demonstrated increased FDG
uptake in the upper and lower lobes of the right
lung. High-resolution chest computed tomogra-
phy (CT) subsequently showed several lesions
with hypodense centres in the upper and lower
lobes of the right lung, compatible with fungal
abscesses. High-resolution chest CT after 6 weeks
showed regression of the pulmonary densities.
After 9 weeks, FDG-PET was normal and treat-
ment with ﬂuconazole was discontinued.
Patient B, a female aged 39 years, had received
TPN because of chronic intestinal pseudo-
obstruction since October 2003. In November
2003, she was admitted because of fever and
rigors. Repeated blood cultures grew C. albicans,
which was also cultured from the catheter tip
after removal, with a ﬂuconazole MIC of
0.125 mg ⁄L. The patient was treated with intra-
venous ﬂuconazole 400 mg daily. Fever persisted
and the clinical condition deteriorated. Blood
cultures remained positive for C. albicans for
2 days after the start of ﬂuconazole. Abdominal
ultrasound and Doppler ultrasonography of the
subclavian and internal jugular veins were both
normal. Chest X-ray was judged to be normal, but
showed a small inﬁltrate in the left lower lobe
upon re-examination. FDG-PET, performed
1 week after admission, demonstrated increased
Corresponding author and reprint requests: C. P. Bleeker-
Rovers, Department of Nuclear Medicine 565, Radboud Uni-
versity Nijmegen Medical Centre, PO Box 9101, 6500 HB
Nijmegen, The Netherlands
E-mail: c.bleeker-rovers@nucmed.umcn.nl
 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
FDG uptake in multiple foci in both lungs and
subpleural, suggesting abscesses (Fig. 1a). Two
days later, the patient developed pleuritic chest
pain and a pleural rub on the right side. Chest CT
showed multiple densities in both lungs compat-
ible with fungal abscesses. Fluconazole was re-
placedby caspofungin.After 3 weeks, caspofungin
was replaced by oral ﬂuconazole. After 7 weeks,
chest CT showed regression of the lung abscesses.
After 9 weeks, FDG-PET was normal (Fig. 1b) and
antifungal treatment was discontinued.
Patient C, a female aged 65 years, had been
treated with prednisone and azathioprine since
1995 because of mixed connective tissue disease.
In May 2004, the patient was admitted to the
intensive care unit with Streptococcus pneumoniae
pneumonia which required mechanical ventila-
tion. Blood cultures remained sterile. Ten days
after admission, blood cultures grew Candida
glabrata. However, C. albicans and C. glabrata were
both isolated from the CVC after removal, with
ﬂuconazole MICs of 4 and 8 mg ⁄L, respectively.
The patient was treated with intravenous ﬂucon-
azole 400 mg daily, but the fever persisted and
the dose was increased to 800 mg daily. Chest
X-ray showed continued inﬁltrative changes in
the left lower lobe. Abdominal CT revealed no
signs of focal infection. Doppler ultrasonography
of the subclavian and internal jugular vein was
normal. The fever still persisted and blood cul-
tures were positive for C. glabrata at 13 days after
the start of ﬂuconazole treatment. FDG-PET,
performed after 12 days of therapy, showed
increased FDG uptake in multiple foci in both
lungs which suggested abscesses. Fluconazole
was replaced by caspofungin. One week later,
chest CT showed inﬁltrative changes in both
upper lobes, compatible with metastatic infec-
tious foci. After 6 weeks of antifungal treatment,
CT showed improvement of the chest inﬁltrative
changes and caspofungin was discontinued. FDG-
PET has not been repeated.
These cases illustrate the difﬁculties in diagno-
sis and treatment of complicated catheter-related
candidiasis. FDG-PET clearly revealed the sites of
the disseminated Candida infection, which was
conﬁrmed by clinical signs (patient B), ﬁndings on
chest CT, and response to antifungal therapy
(patients A, B and C). In patients A and B, FDG-
uptake normalised after prolonged treatment, in
agreement with favourable clinical and laboratory
responses, thereby enabling evaluation of the
effect of antifungal treatment.
Candida spp. adhere avidly to vascular cathe-
ters. CVCs, even when not the primary source of
candidaemia, may continue to serve as the source
of sustained fungaemia as organisms adhere to
the catheter surface and subsequently seed to
target organs [5]. In a retrospective study in this
hospital, 43 of 147 patients treated for candidae-
mia developed disseminated disease [6]; how-
ever, documented Candida lung abscesses are rare.
In a study of 11 patients diagnosed with pulmon-
ary candidiasis at necropsy, six cases were attrib-
uted to CVCs [7].
In patients A, B and C, chest X-ray did not
reveal the lung abscesses, and is therefore not an
appropriate diagnostic method to exclude dis-
seminated pulmonary candidiasis. CT and
ultrasonography are useful for diagnosing dis-
seminated candidiasis, but are less suitable as
screening methods for patients with candidaemia
and suspected disseminated infection, but with-
out clues to the speciﬁc sites of infection. Further-
more, these imaging techniques are not able to
detect infectious foci at an early phase because of
the absence of substantial anatomical changes at
that time. Also, discrimination between active
Fig. 1. (a) Increased uptake of
18F-ﬂuorodeoxyglucose in multiple
foci in both lungs by positron emis-
sion tomography in patient B.
(b) Normal 18F-ﬂuorodeoxyglucose
positron emission tomography scan
after three months in patient B.
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infection and residual changes remains difﬁcult,
which is a drawback during follow-up of the
effect of treatment.
Scintigraphic imaging allows delineation of foci
localised in all parts of the body, based on
functional changes of tissues. FDG-PET, an estab-
lished imaging tool in oncology, is now being
used for the diagnosis of clinical infectious dis-
eases. After cellular uptake, FDG, an analogue of
glucose, is trapped metabolically and provides an
image which portrays glucose utilisation. Inﬂam-
matory cells take up large amounts of glucose as a
result of an increased metabolic rate [8]. Previ-
ously, FDG-PET has proved valuable in diagno-
sing soft tissue infections, osteomyelitis,
intravascular infections and fever of unknown
origin [9,10]. Compared with conventional nuc-
lear medicine techniques (67gallium citrate and
labelled leukocytes), the advantages of FDG-PET
are early imaging and higher spatial resolution,
resulting in more anatomical information [11].
Overall, FDG-PET appears to be a promising new
imaging technique that enables early identiﬁca-
tion of the sites of disseminated Candida infection,
as well as allowing the effect of antifungal
treatment to be evaluated.
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ABSTRACT
Predisposing factors, antimicrobial susceptibility
patterns, treatment and outcome were analysed
for nine consecutive patients with nocardiosis.
Predisposing factors were identiﬁed in six (67%)
of the nine patients. Clinical syndromes of nocar-
dial infection were pulmonary infection (three
patients), cerebral infection (ﬁve patients) and
disseminated infection (one patient). The pre-
dominant (60%) species was Nocardia farcinica
rather than the Nocardia asteroides complex. Treat-
ment was started empirically, modiﬁed according
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